Drug-related problems identified in medication reviews by Australian pharmacists

Research output: Contribution to journalJournal article

Standard

Drug-related problems identified in medication reviews by Australian pharmacists. / Stafford, Andrew C; Tenni, Peter C; Peterson, Gregory M; Jackson, Shane L; Hejlesen, Anne; Villesen, Christine; Rasmussen, Mette.

In: Pharmacy World and Science, Vol. 31, No. 2, 2009, p. 216-23.

Research output: Contribution to journalJournal article

Harvard

Stafford, AC, Tenni, PC, Peterson, GM, Jackson, SL, Hejlesen, A, Villesen, C & Rasmussen, M 2009, 'Drug-related problems identified in medication reviews by Australian pharmacists', Pharmacy World and Science, vol. 31, no. 2, pp. 216-23. https://doi.org/10.1007/s11096-009-9287-y

APA

Stafford, A. C., Tenni, P. C., Peterson, G. M., Jackson, S. L., Hejlesen, A., Villesen, C., & Rasmussen, M. (2009). Drug-related problems identified in medication reviews by Australian pharmacists. Pharmacy World and Science, 31(2), 216-23. https://doi.org/10.1007/s11096-009-9287-y

Vancouver

Stafford AC, Tenni PC, Peterson GM, Jackson SL, Hejlesen A, Villesen C et al. Drug-related problems identified in medication reviews by Australian pharmacists. Pharmacy World and Science. 2009;31(2):216-23. https://doi.org/10.1007/s11096-009-9287-y

Author

Stafford, Andrew C ; Tenni, Peter C ; Peterson, Gregory M ; Jackson, Shane L ; Hejlesen, Anne ; Villesen, Christine ; Rasmussen, Mette. / Drug-related problems identified in medication reviews by Australian pharmacists. In: Pharmacy World and Science. 2009 ; Vol. 31, No. 2. pp. 216-23.

Bibtex

@article{31efe62014a111df803f000ea68e967b,
title = "Drug-related problems identified in medication reviews by Australian pharmacists",
abstract = "OBJECTIVE: In Australia, accredited pharmacists perform medication reviews for patients to identify and resolve drug-related problems. We analysed the drug-related problems identified in reviews for both home-dwelling and residential care-facility patients. The objective of this study was to examine the number and nature of the drug-related problems identified and investigate differences between each type of review. SETTING: Australian patients living at home or in residential care-facilities. METHOD: We collected a nation-wide sample of medication reviews conducted between 1998 and 2005. These reviews had been self-selected by pharmacists and submitted as part of the reaccreditation process to the primary body responsible for accrediting Australian pharmacists to perform medication reviews. The drug-related problems identified in each review were classified by type and drugs involved. MAIN OUTCOME MEASURE: The number and nature of drug-related problems identified in pharmacist-conducted medication reviews. RESULTS: There were 1,038 drug-related problems identified in 234 medication reviews (mean 4.6 (+/-2.2) problems per review). The number of problems was higher (4.9 +/- 2.0 vs. 3.9 +/- 2.2; P < 0.001) in reviews for home-dwelling patients compared with care-facility residents. The number of clinically-significant problems was higher (2.1 +/- 1.1 vs. 1.5 +/- 0.7; P < 0.001) for home-dwelling patients. Oral hypoglycaemics and analgesics/antipyretics were significantly more likely to be associated with problems in home-dwelling patients than in residential care-facility patients. CONCLUSION: These data illustrate the prevalence of drug-related problems and the ability of pharmacists to identify these problems in the Australian models of medication review. The nature and frequency of problems varied between reviews for home-dwelling and care-facility patients. Such information may be used to better focus the training of practitioners based on the most frequently encountered health problems and the nature of common drug-related problems in the two settings.",
keywords = "Former Faculty of Pharmaceutical Sciences",
author = "Stafford, {Andrew C} and Tenni, {Peter C} and Peterson, {Gregory M} and Jackson, {Shane L} and Anne Hejlesen and Christine Villesen and Mette Rasmussen",
note = "Keywords: Aged; Aged, 80 and over; Australia; Drug Toxicity; Drug Utilization Review; Female; Home Care Services; Humans; Male; Medication Therapy Management; Pharmacists; Residential Facilities",
year = "2009",
doi = "10.1007/s11096-009-9287-y",
language = "English",
volume = "31",
pages = "216--23",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7703",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Drug-related problems identified in medication reviews by Australian pharmacists

AU - Stafford, Andrew C

AU - Tenni, Peter C

AU - Peterson, Gregory M

AU - Jackson, Shane L

AU - Hejlesen, Anne

AU - Villesen, Christine

AU - Rasmussen, Mette

N1 - Keywords: Aged; Aged, 80 and over; Australia; Drug Toxicity; Drug Utilization Review; Female; Home Care Services; Humans; Male; Medication Therapy Management; Pharmacists; Residential Facilities

PY - 2009

Y1 - 2009

N2 - OBJECTIVE: In Australia, accredited pharmacists perform medication reviews for patients to identify and resolve drug-related problems. We analysed the drug-related problems identified in reviews for both home-dwelling and residential care-facility patients. The objective of this study was to examine the number and nature of the drug-related problems identified and investigate differences between each type of review. SETTING: Australian patients living at home or in residential care-facilities. METHOD: We collected a nation-wide sample of medication reviews conducted between 1998 and 2005. These reviews had been self-selected by pharmacists and submitted as part of the reaccreditation process to the primary body responsible for accrediting Australian pharmacists to perform medication reviews. The drug-related problems identified in each review were classified by type and drugs involved. MAIN OUTCOME MEASURE: The number and nature of drug-related problems identified in pharmacist-conducted medication reviews. RESULTS: There were 1,038 drug-related problems identified in 234 medication reviews (mean 4.6 (+/-2.2) problems per review). The number of problems was higher (4.9 +/- 2.0 vs. 3.9 +/- 2.2; P < 0.001) in reviews for home-dwelling patients compared with care-facility residents. The number of clinically-significant problems was higher (2.1 +/- 1.1 vs. 1.5 +/- 0.7; P < 0.001) for home-dwelling patients. Oral hypoglycaemics and analgesics/antipyretics were significantly more likely to be associated with problems in home-dwelling patients than in residential care-facility patients. CONCLUSION: These data illustrate the prevalence of drug-related problems and the ability of pharmacists to identify these problems in the Australian models of medication review. The nature and frequency of problems varied between reviews for home-dwelling and care-facility patients. Such information may be used to better focus the training of practitioners based on the most frequently encountered health problems and the nature of common drug-related problems in the two settings.

AB - OBJECTIVE: In Australia, accredited pharmacists perform medication reviews for patients to identify and resolve drug-related problems. We analysed the drug-related problems identified in reviews for both home-dwelling and residential care-facility patients. The objective of this study was to examine the number and nature of the drug-related problems identified and investigate differences between each type of review. SETTING: Australian patients living at home or in residential care-facilities. METHOD: We collected a nation-wide sample of medication reviews conducted between 1998 and 2005. These reviews had been self-selected by pharmacists and submitted as part of the reaccreditation process to the primary body responsible for accrediting Australian pharmacists to perform medication reviews. The drug-related problems identified in each review were classified by type and drugs involved. MAIN OUTCOME MEASURE: The number and nature of drug-related problems identified in pharmacist-conducted medication reviews. RESULTS: There were 1,038 drug-related problems identified in 234 medication reviews (mean 4.6 (+/-2.2) problems per review). The number of problems was higher (4.9 +/- 2.0 vs. 3.9 +/- 2.2; P < 0.001) in reviews for home-dwelling patients compared with care-facility residents. The number of clinically-significant problems was higher (2.1 +/- 1.1 vs. 1.5 +/- 0.7; P < 0.001) for home-dwelling patients. Oral hypoglycaemics and analgesics/antipyretics were significantly more likely to be associated with problems in home-dwelling patients than in residential care-facility patients. CONCLUSION: These data illustrate the prevalence of drug-related problems and the ability of pharmacists to identify these problems in the Australian models of medication review. The nature and frequency of problems varied between reviews for home-dwelling and care-facility patients. Such information may be used to better focus the training of practitioners based on the most frequently encountered health problems and the nature of common drug-related problems in the two settings.

KW - Former Faculty of Pharmaceutical Sciences

U2 - 10.1007/s11096-009-9287-y

DO - 10.1007/s11096-009-9287-y

M3 - Journal article

C2 - 19242818

VL - 31

SP - 216

EP - 223

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7703

IS - 2

ER -

ID: 17496386